Literature DB >> 28438868

Survival and Predictors of Death for Patients with Bronchopulmonary Carcinoid at a Danish Tertiary NET Centre.

Linda Skibsted Kornerup1, Gitte Dam2, Henning Gronbaek2.   

Abstract

BACKGROUND/AIM: Bronchopulmonary carcinoids comprise of typical carcioids (TC) and atypical carcinoids (AC). We present characteristics and associated mortality in patients with TC and AC followed-up at a Danish NET Centre between 2000-2014. PATIENTS AND METHODS: Data were obtained from medical records, computed tomographic scans, and pathology reports. Mortality was investigated by Kaplan-Meier survival analysis.
RESULTS: We included 68 patients, 55 with TC (81%) and 13 with AC (19%). Median follow-up was 5.6 years (range=1.0-26.3). Fourteen patients died; 13 were smokers, and nine had a Ki67 index >2%. Metastatic disease, smoking and male gender were significantly associated with risk of dying within the first 5 years (log-rank, all p<0.05), while Ki67 index >2% showed a trend for being associated with risk of death (p=0.11).
CONCLUSION: Survival is strongly associated with tumor type and current/previous smoking. Metastatic disease at diagnosis and male gender are predictors of death within 5 years. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Ki67 index; Neuroendocrine tumors; atypical; bronchial neuroendocrine tumors; carcinoid; typical

Mesh:

Year:  2017        PMID: 28438868      PMCID: PMC5461450          DOI: 10.21873/invivo.11072

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  19 in total

Review 1.  The new World Health Organization classification of lung tumours.

Authors:  E Brambilla; W D Travis; T V Colby; B Corrin; Y Shimosato
Journal:  Eur Respir J       Date:  2001-12       Impact factor: 16.671

2.  Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach.

Authors:  Tina Zahel; Sabine Krysa; Esther Herpel; Albrecht Stenzinger; Benjamin Goeppert; Peter Schirmacher; Hans Hoffmann; Philipp A Schnabel; Arne Warth
Journal:  Virchows Arch       Date:  2012-03       Impact factor: 4.064

3.  Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.

Authors:  Johannes Voortman; Jih-Hsiang Lee; Jonathan Keith Killian; Miia Suuriniemi; Yonghong Wang; Marco Lucchi; William I Smith; Paul Meltzer; Yisong Wang; Giuseppe Giaccone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

Review 4.  Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature.

Authors:  G Fink; T Krelbaum; A Yellin; D Bendayan; M Saute; M Glazer; M R Kramer
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

5.  Long-term outcome after resection for bronchial carcinoid tumors.

Authors:  M K Ferguson; R J Landreneau; S R Hazelrigg; N K Altorki; K S Naunheim; J B Zwischenberger; M Kent; A P Yim
Journal:  Eur J Cardiothorac Surg       Date:  2000-08       Impact factor: 4.191

6.  [CGH findings in neuroendocrine tumours of the lung].

Authors:  G Johnen; M Krismann; M Jaworska; K-M Müller
Journal:  Pathologe       Date:  2003-05-15       Impact factor: 1.011

7.  Bronchial carcinoid tumors: nodal status and long-term survival after resection.

Authors:  Giuseppe Cardillo; Francesco Sera; Marco Di Martino; Paolo Graziano; Roberto Giunti; Luigi Carbone; Francesco Facciolo; Massimo Martelli
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

8.  Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.

Authors:  Manal M Hassan; Alexandria Phan; Donghui Li; Cecile G Dagohoy; Colleen Leary; James C Yao
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

Review 9.  Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice.

Authors:  Giuseppe Pelosi; Guido Rindi; William D Travis; Mauro Papotti
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

10.  Bronchial carcinoids. A review of 22 cases.

Authors:  M Froudarakis; P Fournel; G Burgard; D Bouros; S Boucheron; N M Siafakas; A Emonot
Journal:  Oncology       Date:  1996 Mar-Apr       Impact factor: 2.935

View more
  2 in total

1.  Bronchial carcinoid tumors: second primary neoplasms and outcomes of surgical treatment.

Authors:  Jefferson Luiz Gross; Marcel Adalid Tapia Vega; Guilherme Strambi Frenhi; Silvio Melo Torres; Antonio Hugo José Froes Marques Campos; Clovis Antonio Lopes Pinto; Felipe D'Almeida Costa; Fabio José Haddad
Journal:  J Bras Pneumol       Date:  2019-09-16       Impact factor: 2.624

2.  NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids.

Authors:  Irene Gagliardi; Mario Tarquini; Maria Rosaria Ambrosio; Elisa Giannetta; Patricia Borges de Souza; Roberta Gafà; Aldo Carnevale; Paola Franceschetti; Maria Chiara Zatelli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-08       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.